TrialDiabetes care2023

Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders.

Mark R Rigby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.